|

Loratadine Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Also known as: Claritin

Pipeline

Early 1: 1Phase 4: 1

Top Sponsors

  • Rutgers, The State University of New Jersey1
  • Emory University1
  • Alexandria University1

Indications

  • Cancer3
  • Plasma Cell Myeloma1
  • Bone Pain1
  • Neutropenia1
  • Hematologic Malignancy1

Other1 trial

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
N/A

Atlanta, Georgia1 trial

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University Hospital/Winship Cancer Institute

Phase 4

New Brunswick, New Jersey1 trial

Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

Rutgers Cancer Institute of New Jersey

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.